MedTrace Logo

Management of Cerebral Vascular Spasm in Posttraumatic Subarachnoid Hemorrhage Using Combination Therapy

NCT05131867 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-05-25

No results posted yet for this study

Summary

To evaluate the efficacy and safety of oral Nimodipine and IV milrinone combination therapy for management of cerebral spasm after aneurysmal subarachnoid hemorrhage.

Conditions

  • Oral Nimodipine
  • Milrinone
  • Vascular Spasm After Traumatic Subarachnoidhaemorrhage

Interventions

DRUG

nimodipine

(60 mg/4 hours) orally or via nasogastric tube

DRUG

Oral Nimodipine and milrinone

Oral Nimodipine then after the diagnosis of vasospasm is confirmed, start milrinone bolus

Sponsors & Collaborators

  • Zagazig University

    lead OTHER_GOV

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-24
Primary Completion
2022-05-23
Completion
2022-05-24

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05131867 on ClinicalTrials.gov